NATUREX : Number of shares and voting rights as at 31 December 2015 information fournie par Actusnews 11/01/2016 à 18:00
Number of shares and voting rights
Article L.233-8-II of Commercial Law (Code de commerce) and
Article 223-16 of the General Regulation of the French Financial Markets Authority
(AMF - Autorité des Marchés Financiers)
Press release
Avignon, January 11
th
, 2016
31.12.2015
Total number of outstanding shares forming the capital
- 9,236,634 ordinary shares under ISIN FR0000054694 - 2,216 shares issued from stock-options under ISIN FR0000054694 | 9,238,850 |
Number of shares with double voting rights | 2,099,773 |
Total number of gross voting rights | 11,338,623 |
Number of shares without voting rights
- 4,488 bearer shares in the frame of the liquidity contract | - 4,488 |
Total number of exercisable voting rights* | 11,334,135 |
* Exercisable voting rights = total number of voting rights - number of shares without voting rights
You can receive all financial information of Naturex free of charge by signing up at: www.naturex.com
-
Financial schedule
Revenue - FY 2015 04 February 2016 Results - FY 2015 30 March 2016
-
Upcoming events
SFAF Analysts Meeting 31 March 2016 General Meeting 21 June 2016
Naturex has been listed since October 1996 on Euronext in Paris, Segment B
Total number of shares comprising the share capital: 9,238,850 (December 2015)
ISIN FR0000054694 Naturex is a component of the CACT, Enternext CAC PEA-PME 150, CAC Small & Mid, CAC Small, Gaïa Index. Naturex is eligible for the "long only" Deferred Settlement Service (SRD) and French equity plans (PEA and PEA-PME). Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY. TICKER: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR SYMBOL: NTUXY |
About Naturex
Naturex is the global leader in speciality plant-based natural ingredients. The Group is organised around three strategic markets (Food & Beverage, Nutrition & Health and Personal Care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.
Naturex's head office is based in Avignon. The company employs 1,700 people with 8 sourcing offices located throughout the world and high-performance manufacturing operations across 15 sites in Europe, Morocco, the United States, Brazil, Australia and India. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries.
- Contacts
Carole Alexandre
Investor Relations Tel.: +33 (0)4 90 23 78 28 c.alexandre@naturex.com |
Anne Catherine Bonjour
Actus Finance Press Relations Tel.: +33 (0)1 53 67 36 93 acbonjour@actus.fr |
Information réglementée
Information relative au nombre total de droits de vote et d'actions composant le capital :
-
Full and original press release in PDF:
http://www.actusnews.com/documents_communiques/ACTUS-0-42707-cp-naturex_110116.pdf